Defects in leukocyte-mediated initiation of lipid peroxidation in plasma as studied in myeloperoxidase-deficient subjects: systematic identification of multiple endogenous diffusible substrates for myeloperoxidase in plasma
Open Access
- 1 March 2002
- journal article
- Published by American Society of Hematology in Blood
- Vol. 99 (5) , 1802-1810
- https://doi.org/10.1182/blood.v99.5.1802.h8001802_1802_1810
Abstract
More than a decade ago it was demonstrated that neutrophil activation in plasma results in the time-dependent formation of lipid hydroperoxides through an unknown, ascorbate-sensitive pathway. It is now shown that the mechanism involves myeloperoxidase (MPO)-dependent use of multiple low-molecular–weight substrates in plasma, generating diffusible oxidant species. Addition of activated human neutrophils (from healthy subjects) to plasma (50%, vol/vol) resulted in the peroxidation of endogenous plasma lipids by catalase-, heme poison-, and ascorbate-sensitive pathways, as assessed by high-performance liquid chromatography (HPLC) with on-line electrospray ionization tandem mass spectrometric analysis of free and lipid-bound 9-HETE and 9-HODE. In marked contrast, neutrophils isolated from multiple subjects with MPO deficiency failed to initiate peroxidation of plasma lipids, but they did so after supplementation with isolated human MPO. MPO-dependent use of a low-molecular–weight substrate(s) in plasma for initiating lipid peroxidation was illustrated by demonstrating that the filtrate of plasma (10-kd MWt cutoff) could supply components required for low-density lipoprotein lipid peroxidation in the presence of MPO and H2O2. Subsequent HPLC fractionation of plasma filtrate (10-kd MWt cutoff) by sequential column chromatography identified nitrite, tyrosine, and thiocyanate as major endogenous substrates and 17β-estradiol as a novel minor endogenous substrate in plasma for MPO in promoting peroxidation of plasma lipids. These results strongly suggest that the MPO–H2O2system of human leukocytes serves as a physiological mechanism for initiating lipid peroxidation in vivo.Keywords
This publication has 76 references indexed in Scilit:
- Myeloperoxidase-generated oxidants and atherosclerosisFree Radical Biology & Medicine, 2000
- Lipoxygenases and atherosclerosis: protection versus pathogenesisFree Radical Biology & Medicine, 2000
- Leukocytes Utilize Myeloperoxidase-Generated Nitrating Intermediates as Physiological Catalysts for the Generation of Biologically Active Oxidized Lipids and Sterols in SerumBiochemistry, 1999
- The Oxidation of Lipoproteins by Monocytes-MacrophagesJournal of Biological Chemistry, 1999
- Oxidized LDL and AtherogenesisaAnnals of the New York Academy of Sciences, 1999
- The role of oxidized lipoproteins in atherogenesisPublished by Elsevier ,1999
- Leukotrienes and Other Products of the 5-Lipoxygenase PathwayNew England Journal of Medicine, 1990
- Beyond CholesterolNew England Journal of Medicine, 1989
- ARACHIDONIC ACID METABOLISMAnnual Review of Biochemistry, 1986
- Prostaglandins, Arachidonic Acid, and InflammationScience, 1980